MENLO PARK, CA (October 26, 2021) – SRI International announced today that its Board of Directors has appointed Dr. David E. Parekh as CEO, effective December 1st, 2021. David Parekh has had a storied career in technology research and development, most recently as an independent consultant as well as serving on various boards, including those […]
Announcements
SRI International selected to participate in DARPA’s Quantum Apertures program
SRI International is excited to announce the institute is one of four teams selected to participate in Defense Advanced Research Projects Agency (DARPA)’s Quantum Apertures (QA) program. The QA program’s goal is to develop portable and directional RF antennas and RF receivers with significantly greater sensitivity, bandwidth and dynamic range than any classical receiver available […]
SRI International’s Parijat Bhatnagar receives DARPA award to continue groundbreaking research into engineered immunity
The prestigious award provides additional funds to continue developing cells that can be stimulated via extracorporeal devices to treat viral infections
SRI leads collaborative effort that uncovered cybersecurity issues in industrial control system safety instrumentation and management
SRI worked with penetration testers and LOGIIC safety system experts to improve overall security of ICS safety systems
SRI International releases major update to its BioCyc family of websites
SRI International is pleased to announce a major update to the BioCyc family of websites. SRI’s BioCyc solution features a collection of nearly 18,000 Pathway/ Genome Databases (PGDBs) for sequenced bacteria and major eukaryotes and supporting software tools. BioCyc provides a reference on the genomes, metabolic pathways of thousands of sequenced organisms and the regulatory networks of some of the organisms. BioCyc data is obtained by combining computational inferences, import data from other databases, and […]
SRI International receives IARPA contract for rapid, breath-based disease-detection system
SRI International has been awarded a contract under the Intelligence Advanced Research Projects Activity (IARPA) to evaluate whether a novel, prototype technology has the potential to detect COVID-19 and other infectious diseases through exhaled human breath. The rapid, noninvasive technology is designed to provide widespread disease screening in places such as malls, airports, stadiums, emergency […]
SRI International receives contract on Ditto Project under DARPA AI Exploration Program
SRI International has been awarded a contract under the DARPA Ditto Project, which is a part of the Agency’s AI Exploration Program. The Ditto project seeks to use microelectronic system simulation to explore third-wave artificial intelligence (AI) solutions that incorporate real-world knowledge into modern machine learning (ML) functions and systems. Ditto seeks to build an […]
Expanding cancer immunotherapy by exploiting recall immunity – a new co-therapy option for checkpoint inhibitor
Immune checkpoint inhibitors (CIs) have emerged as a revolutionary treatment for several cancer types. They enhance immune recognition by silencing checkpoints and allowing T-cells to attack tumor cells. Despite the significant improvement in prognosis for some cancer patients, there are challenges in using CIs for the treatment of all cancers. To address this challenge, SRI […]
SRI introduces DiaCyt™ CNS drug-delivery platform at 2021 JP Morgan Conference
Novel peptide-based technology delivers molecular cargo through the blood brain barrier, enabling CNS drug discovery and therapeutic delivery
